Hamza Bhatti, DO
MOHS-Micrographic Surgery · New York, NYNPI 1043598352
Payments from drug & device makers
Across 367 payments — averaging $108.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Regeneron Healthcare Solutions, Inc.$31K
- Incyte Corporation$1K
- Amgen$997
- Sanofi$944
- AbbVie$894
- Johnson & Johnson$765
- plus $4K from 21 others
What the payments were for
- Consulting fees$2,9757%
- Speaking & faculty fees$24,18361%
- Travel & lodging$2,8587%
- Food & beverage$9,63724%
- Education$2951%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 72 | $31,455 |
| Incyte Corporation | 41 | $1,246 |
| Amgen | 19 | $997 |
| Sanofi | 20 | $944 |
| AbbVie(2 entities) | 31 | $894 |
| Johnson & Johnson | 15 | $765 |
| E.r. Squibb & Sons, L.L.C. | 39 | $629 |
| Biofrontera Inc. | 18 | $422 |
| Lilly USA, LLC | 13 | $419 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 13 | $313 |
| Galderma Laboratories, L.p. | 11 | $281 |
| Novartis | 10 | $270 |
| LEO Pharma Inc. | 27 | $244 |
| Pfizer | 6 | $237 |
| Dermavant Sciences, Inc. | 2 | $192 |
| Almirall LLC | 10 | $172 |
| Organogenesis Inc. | 4 | $94 |
| Sun Pharmaceutical Industries Inc. | 5 | $83 |
| Merz North America, Inc. | 1 | $65 |
| Biowound Solutions, Inc. | 1 | $48 |
| Verrica Pharmaceuticals Inc. | 1 | $43 |
| UCB, Inc. | 2 | $38 |
| VYNE Pharmaceuticals Inc. | 2 | $29 |
| Mimedx Group, Inc. | 1 | $25 |
| EPI Health, LLC | 1 | $15 |
| Journey Medical Corporation | 1 | $14 |
| Strata Skin Sciences, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$39,947 in reported general payments places this provider in the 85th percentile of 75 mohs-micrographic surgery providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 34 | $142,034 |
| Mupirocin | 826 | $6,090 |
| Fluorouracil | 19 | $869 |
| Ketoconazole | 16 | $168 |
| Cephalexin | 25 | $130 |
| Triamcinolone Acetonide | 19 | $110 |
| Doxycycline Hyclate | 21 | $105 |
| Amoxicillin | 21 | $69 |
Paid to pharmacies, not to this prescriber.
Other mohs-micrographic surgery in New York
- John CarucciNew York$618K
- Ellen MarmurNew York$186K
- Michael TassavorNew York$55K
- Jane YooNew York$42K
- Faramarz SamieNew York$33K
- Desiree RatnerNew York$32K
- Omar Torres LozadaNew York$13K
- Ronald SheltonNew York$10K
- Sarah YagermanNew York$8K
- Hooman KhorasaniNew York$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.